“Efficacy of Ibrutinib in the Treatment of Monoclonal Gammopathy of Renal Significance With C3 Deposits Secondary to Chronic Lymphocytic Leukemia”. Archives of Clinical and Biomedical Research 9, no. 5 (September 22, 2025): 360–363. Accessed September 17, 2026. https://fortunejournals.org/ojs/index.php/acbr/article/view/15131.